News Focus
News Focus
icon url

bow-tie

05/21/20 9:48 PM

#18137 RE: Work Harder #18136

Lonza is involved in the manufacturing of biologics with several pharmaceutical companies. Lonza entered into a partnership with Teva in 2009 to develop and manufacture biosimilars. In 2010, they made a deal with GlaxoSmithKline to manufacture therapeutic monoclonal antibodies. In 2014, Lonza entered into an agreement with Bristol-Myers Squibb to manufacture two biologic drugs. Lonza also manufactures Imbruvica for Pharmacyclics and Mydicar for Celladon. In 2015, Lonza contracted with Alexion to construct a new facility dedicated to Alexion manufacturing. In 2017, Lonza and Sanofi partnered to construct a new facility for production of biologics.[5]

https://en.wikipedia.org/wiki/Lonza_Group
icon url

bow-tie

05/21/20 9:59 PM

#18138 RE: Work Harder #18136

ZURICH (Reuters) - Swiss drugmaker-for-hire Lonza (LONN.S) is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative raw materials of a medical revolution.

https://www.reuters.com/article/us-lonza-gene-therapy-idUSKBN1HH18I